Results 151 to 160 of about 4,920 (197)

Sodium-Glucose Cotransporter-2-inhibitors in Adult Patients With Alport Syndrome. [PDF]

Kidney Int Rep
Toso D, Cinquina V, Econimo L, Cortinovis R, Zeni L, Tornambè V, Dordoni C, Ritelli M, Savoldi G, Mazza C, Scolari F, Alberici F, Izzi C.   +12 more
europepmc   +1 more source

New Insights in Fibroblast Growth Factor 23 Pathobiology in Kidney Diseases. [PDF]

J Am Soc Nephrol
Jansson KP.
europepmc   +1 more source

Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial. [PDF]

Clin J Am Soc Nephrol
Yee J, Gong W, Inrig J, Rheault MN, Gruber AJ, Bedard PW, Komers R, Trachtman H, Trachtman H.   +8 more
europepmc   +1 more source

Genetic diagnosis of hereditary kidney disease in pediatric patients through whole-exome sequencing and mitochondrial DNA analysis. [PDF]

Kidney Res Clin Pract
Oh J, Lee K, Won D, Lee YM, Shin JI.
europepmc   +1 more source

Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells. [PDF]

Kidney360
Zheng Q, Zhao Y, Jin Y, Yu S, Liu Y, Yu H, Fang Z, Yang L, Weng Q, Xu J, Pan X, Gu X, Xie J.   +12 more
europepmc   +1 more source

Update on Alport Syndrome: The Report of the 2024 International Workshop on Alport Syndrome. [PDF]

Kidney Int Rep
Oates TM, Barua M, Gear S, Turner AN, Lennon R, Kai H, Gale DP, Aksenova M, Savige J, Gross O, Massella L, Miner JH, Deltas C.   +12 more
europepmc   +1 more source

Whole transcriptome sequencing and ceRNA regulatory network in diabetic peripheral neuropathy. [PDF]

Sci Rep
Yan Q, Zhang M, Xu LJ, Ma J, Wang J, Wang XM, Ma L.   +6 more
europepmc   +1 more source

Kidney transplantation in Alport syndrome: A genotype-guided case series and literature review. [PDF]

Turk J Surg
Gavrilovska-Brzanov A, Sulejmani H, Dohcev S, Spasovski G, Georgievski N, Trifunovski A, Trajkovski D, Jovanovski Srceva M, Brzanov N.   +8 more
europepmc   +1 more source